Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionDividends Paid - CommonFree Cash FlowLong-Term Debt RepaymentsNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShort-Term Debt issuances
Growth Metrics
Income Statement
Others
Ratios

Selectis Health (GBCS) Cash from Operations (2017 - 2025)

Selectis Health's Cash from Operations history spans 14 years, with the latest figure at 280028.0 for Q3 2025.

  • For Q3 2025, Cash from Operations rose 122.81% year-over-year to 280028.0; the TTM value through Sep 2025 reached 839136.0, up 125.78%, while the annual FY2024 figure was 1800000.0, 435.4% down from the prior year.
  • Cash from Operations for Q3 2025 was 280028.0 at Selectis Health, up from 77379.0 in the prior quarter.
  • Across five years, Cash from Operations topped out at 2358249.0 in Q3 2023 and bottomed at 1854225.0 in Q4 2023.
  • The 5-year median for Cash from Operations is 66995.0 (2023), against an average of 31650.11.
  • The largest annual shift saw Cash from Operations soared 5772.95% in 2022 before it tumbled 636.68% in 2023.
  • A 5-year view of Cash from Operations shows it stood at 1333834.0 in 2021, then tumbled by 74.1% to 345500.0 in 2022, then crashed by 636.68% to 1854225.0 in 2023, then surged by 78.49% to 398924.0 in 2024, then soared by 170.2% to 280028.0 in 2025.
  • Per Business Quant, the three most recent readings for GBCS's Cash from Operations are 280028.0 (Q3 2025), 77379.0 (Q2 2025), and 1035411.0 (Q1 2025).